Partner with Ophidion 2018-08-03T10:13:07-04:00

Partner with Ophidion

Ophidion CNS Carrier Technology

Ophidion’s CNS Carrier Technology (or OCCT) is available for partnering. We look forward to enable third parties to enhance the penetration of their pipeline or marketed products (life cycle management) to the brain. The OCCT can be coupled with small molecules, including peptides, gene silencing therapies, siRNA’s and other macromolecules (e.g. antibodies, oligonucleotides, etc.).

Ophidion’s CNS Pipeline

Ophidion is seeking to out-license the Analgesia (OCCT-neurotensin) program as well as the Anxiety program on a world-wide basis. In addition, Ophidion is looking for a co-development partners for the Huntington’s (OCCT-HTT siRNA) and Cognition (OCCT-lynx1 siRNA) programs in the USA and for out-licensing the rights for these two programs outside the USA, including Europe, China, and Japan.

Partnering Opportunities

Ophidion’s CNS Carrier Technology (OCCT)

  • Available for partnering with third parties’ pipeline or marketed products

Cognition (OCCT-lynx1 siRNA)

  • Available for partnering in ex-U.S. regions (Europe, China and Japan)
  • For U.S.: looking for co-development partner

Huntington’s disease (OCCT-HTT siRNA)

  • Available for partnering in ex-U.S. regions (Europe, China and Japan)
  • For U.S.: looking for co-development partner

Analgesia (OCCT-NT)

  • Available for outlicensing on a worldwide basis

Anxiety

  • Available for outlicensing on a worldwide basis

Contact

For interest in partnering, contact Yacoub Habib, CEO
Tel: (610) 308-9020
Email: [email protected]